G medical innovations holdings ltd. (nasdaq: gmvd) announces share repurchase program

Irvine, california, may 20, 2022 (globe newswire) -- g medical innovations holdings ltd. (nasdaq: gmvd) (the “company”) today announced that its board of directors has authorized a share repurchase program to acquire up to $1 million of the company's ordinary shares (the “repurchase plan”). the company may purchase ordinary shares from time to time in the open market, through privately negotiated transactions, or any other legally permissible ways, depending on market conditions, share price, trading volume and other factors. such repurchases shall be made in compliance with the rules of the united states securities and exchange commission (the “sec”) and other applicable legal requirements. as of may 17th, 2022, the company had approximately $3 million of cash, $6 million in account receivables and had 24,386,680 ordinary shares outstanding.
GMVD Ratings Summary
GMVD Quant Ranking